TSPO缺失诱导线粒体功能障碍,导致胶质母细胞瘤缺氧、血管生成及促生长代谢向糖酵解转变
该研究利用TSPO敲除异种移植和自发小鼠胶质瘤模型,发现TSPO缺失促进胶质瘤细胞增殖、肿瘤生长和血管生成,并伴随线粒体碎片化增加、葡萄糖摄取和乳酸转化增多、氧化磷酸化降低和糖酵解增强。结论表明TSPO通过调控线粒体氧化磷酸化与糖酵解的代谢平衡,成为胶质瘤生长和恶性的关键调节因子。
要点
- TSPO缺失促进胶质瘤生长和血管生成
- TSPO调控线粒体氧化磷酸化与糖酵解的平衡
- TSPO缺失导致线粒体碎片化增加和代谢向糖酵解转变
核心结论
- TSPO通过控制线粒体氧化磷酸化与糖酵解的代谢平衡,成为胶质瘤生长和恶性的关键调节因子。
研究设计与样本
- 采用TSPO敲除异种移植和自发小鼠胶质瘤模型评估TSPO在胶质瘤发病中的作用。
- 使用Seahorse Extracellular Flux Analyzer评估TSPO敲除和野生型胶质瘤细胞的线粒体氧化磷酸化和糖酵解。
主要发现
- TSPO缺失在体外促进小鼠GL261细胞和患者来源干细胞样GBM1B细胞的胶质瘤细胞增殖。
- TSPO敲除增加颅内异种移植和自发小鼠胶质瘤模型中的胶质瘤生长和血管生成。
- TSPO缺失导致更多碎片化线粒体、葡萄糖摄取和乳酸转化增加、氧化磷酸化降低和糖酵解增加。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The ligands of mitochondrial translocator protein (TSPO) have been widely used as diagnostic biomarkers for glioma. However, the true biological actions of TSPO in vivo and its role in glioma tumorigenesis remain elusive. METHODS: TSPO knockout xenograft and spontaneous mouse glioma models were employed to assess the roles of TSPO in the pathogenesis of glioma. A Seahorse Extracellular Flux Analyzer was used to evaluate mitochondrial oxidative phosphorylation and glycolysis in TSPO knockout and wild-type glioma cells. RESULTS: TSPO deficiency promoted glioma cell proliferation in vitro in mouse GL261 cells and patient-derived stem cell-like GBM1B cells. TSPO knockout increased glioma growth and angiogenesis in intracranial xenografts and a mouse spontaneous glioma model. Loss of TSPO resulted in a greater number of fragmented mitochondria, increased glucose uptake and lactic acid conversion, decreased oxidative phosphorylation, and increased glycolysis. CONCLUSION: TSPO serves as a key regulator of glioma growth and malignancy by controlling the metabolic balance between mitochondrial oxidative phosphorylation and glycolysis.1. TSPO deficiency promotes glioma growth and angiogenesis.2. TSPO regulates the balance between mitochondrial oxidative phosphorylation and glycolysis.
引用
- Fu Y, Wang D, Wang H, et al. TSPO deficiency induces mitochondrial dysfunction, leading to hypoxia, angiogenesis, and a growth-promoting metabolic shift toward glycolysis in glioblastoma. Neuro Oncol. 2020. PMID: 31563962. doi:10.1093/neuonc/noz183
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。